Detalles de la búsqueda
1.
Analytical Validation and Clinical Utility of an Immunohistochemical Programmed Death Ligand-1 Diagnostic Assay and Combined Tumor and Immune Cell Scoring Algorithm for Durvalumab in Urothelial Carcinoma.
Arch Pathol Lab Med
; 143(6): 722-731, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30457897
2.
The development and deployment of Common Data Elements for tissue banks for translational research in cancer - an emerging standard based approach for the Mesothelioma Virtual Tissue Bank.
BMC Cancer
; 8: 91, 2008 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-18397527
3.
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.
J Thorac Oncol
; 12(2): 208-222, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27913228
4.
Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N.
Diagn Pathol
; 11(1): 44, 2016 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27189072
5.
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Diagn Pathol
; 11(1): 95, 2016 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717372
Resultados
1 -
5
de 5
1
Próxima >
>>